The Journal of Organic Chemistry
Article
3H); 13C NMR (100 MHz, CDCl3) δ 166.5, 131.7, 131.5, 129.5,
128.7, 128.4, 128.0, 122.7, 92.3, 88.6, 52.2; MS m/z 237 [M + H]+.
General Procedure for the Larock Heteroannulation
(Compounds 8a−g and 9a−g). Pd(OAc)2 (10 mol %, 11.22 mg,
0.05 mmol), 20 mol % of PPh3 (26.22 mg, 0.1 mmol), n-Bu4NCl (139
mg, 0.5 mmol), Na2CO3 (264 mg, 2.50 mmol), 2-iodoaniline (109 mg,
0.5 mmol), DMF (5 mL), and diarylalkyne (0.7 mmol) were added to
a three-necked round-bottom flask equipped with a stirring bar and
condenser. The reaction was heated under N2 atmosphere at 80 °C for
24 h. Then, the reaction mixture was diluted with ether and washed
with saturated NH4Cl solution and H2O. The organic layer was
separated and dried over anhydrous Na2SO4. The reaction mixture was
filtered and concentrated, and the product was purified by column
chromatography using 10% ethyl acetate/hexane.
132.3, 131.6, 128.8, 128.3, 128.1, 127.9, 122.8, 120.6, 120.1, 119.3,
113.7, 110.9; HRMS (ESI-TOF) m/z [M + H]+ calcd for C20H15NBr
348.0388, found 348.0389.
Methyl 4-(3-Phenyl-1H-indol-2-yl)benzoate (8e).34 Pale yellow
1
solid (85.6 mg, 52%): H NMR (400 MHz, DMSO-d6) δ 11.73 (s,
1H), 7.92 (d, J = 8.7 Hz, 2H), 7.58 (d, J = 8.7 Hz, 2H), 7.51−7.29 (m,
7H), 7.20 (t, J = 8.1 Hz, 1H), 7.06 (t, J = 8.0 Hz, 1H), 3.84 (s, 3H);
13C NMR (100 MHz, DMS-d6) δ 165.8, 137.0, 136.4, 134.7, 132.5,
129.7, 129.2, 128.7, 128.0, 127.8, 126.4, 122.6, 120.0, 118.8, 114.9,
111.6, 52.0 ; HRMS (ESI-TOF) m/z [M + H]+ calcd for C22H18NO2
328.1338, found 328.1336.
Methyl 4-(2-Phenyl-1H-indol-3-yl)benzoate (9e).36 Pale yellow
1
solid (45.3 mg, 28%): H NMR (400 MHz, CDCl3) δ 8.39 (s, 1H),
8.03 (d, J = 8.6 Hz, 2H), 7.69 (d, J = 8.1 Hz, 1H), 7.52−7.26 (m, 9H),
7.17 (t, J = 8.0 Hz, 1H), 3.92 (s, 3H); 13C NMR (100 MHz, CDCl3) δ
167.3, 140.4, 136.0, 135.1, 132.3, 129.84, 129.80, 128.8, 128.4, 128.2,
128.0, 127.6, 122.9, 120.7, 119.3, 113.9, 111.1, 52.0; HRMS (ESI-
TOF) m/z [M + H]+ calcd for C22H18NO2 328.1338, found 328.1332.
4-(3-Phenyl-1H-indol-2-yl)benzonitrile (8f).37 White solid (49.7
4-(3-Phenyl-1H-indol-2-yl)aniline (8a). Pale yellow solid (30.4 mg,
1
21%): H NMR (400 MHz, CDCl3) δ 8.11 (s, 1H), 7.65 (d, J = 7.8
Hz, 1H), 7.43 (m, 2H), 7.32 (m, 3H), 7.23 (t, J = 7.3 Hz, 1H), 7.25−
7.08 (m, 4H), 6.52 (d, J = 8.5 Hz, 2H), 4.04−3.14 (bs, 2H); 13C NMR
(100 MHz, CDCl3) δ 145.9, 135.6, 135.5, 134.7, 130.0, 129.3, 128.8,
128.4, 125.8, 122.8, 122.0, 120.1, 119.2, 115.1, 113.3, 110.7; HRMS
(ESI-TOF) m/z [M + H]+ calcd for C20H17N2 285.1392, found
285.1391.
1
mg, 34%): H NMR (400 MHz, CDCl3) δ 8.39 (s, 1H), 7.67 (d, J =
7.7 Hz, 1H), 7.62 (d, J = 8.5 Hz, 2H), 7.52 (d, J = 8.5 Hz, 2H), 7.46−
7.32 (m, 6H), 7.28 (t, J = 7.6 Hz, 1H), 7.16 (t, J = 7.5 Hz, 1H); 13C
NMR (100 MHz, CDCl3) δ 137.2, 136.4, 134.2, 132.3, 131.6, 130.0,
128.8, 128.7, 126.9, 123.7, 120.8, 120.1, 118.8, 117.5, 111.1, 110.5;
HRMS (ESI-TOF) m/z [M + H]+ calcd for C21H15N2 295.1235,
found 295.1238.
4-(2-Phenyl-1H-indol-3-yl)aniline (9a). Pale yellow solid (54.9 mg,
1
39%): H NMR (400 MHz, CDCl3) δ 8.19 (s, 1H), 7.64 (d, J = 8.0
Hz, 1H), 7.45−7.42 (m, 2H), 7.39 (d, J = 8.0 Hz, 1H), 7.34−7.18 (m,
6H), 7.12 (t, J = 7.5 Hz, 1H), 6.72 (d, J = 8.5 Hz, 2H); 13C NMR (100
MHz, CDCl3) δ 144.4, 135.8, 133.4, 133.0, 131.0, 129.0, 128.6, 128.0,
127.4, 125.4, 122.5, 120.2, 119.8, 115.6, 115.1, 110.8; HRMS (ESI-
TOF) m/z [M + H]+ calcd for C20H17N2 285.1392, found 285.1396.
4-(3-Phenyl-1H-indol-2-yl)phenol (8b).32 White solid (32.0 mg,
22%): 1H NMR (400 MHz, DMSO-d6) δ 11.37 (s, 1H), 9.62 (s, 1H),
7.51−7.23 (m, 9H), 7.12 (t, J = 7.5 Hz, 1H), 7.02 (t, J = 7.4 Hz, 1H),
6.76 (d, J = 8.6 Hz, 2H); 13C NMR (100 MHz, DMSO-d6) δ 156.9,
135.7, 135.5, 134.6, 129.5, 129.4, 128.4, 127.9, 125.7, 123.1, 121.3,
119.4, 118.1, 115.3, 111.7, 111.1; HRMS (ESI-TOF) m/z [M + H]+
calcd for C20H16NO 286.1232, found 286.1225.
4-(2-Phenyl-1H-indol-3-yl)benzonitrile (9f).15,38 White solid (29.8
mg, 20%): 1H NMR (400 MHz, DMSO-d6) δ 11.79 (s, 1H), 7.80 (d, J
= 8.1 Hz, 2H), 7.57−7.33 (m, 9H), 7.21 (t, J = 7.3 Hz, 1H), 7.10 (t, J
= 7.4 Hz, 1H); 13C NMR (100 MHz, DMSO-d6) δ 140.6, 136.1, 135.6,
132.3, 131.7, 130.1, 128.6, 128.5, 128.0, 127.0, 122.2, 120.2, 119.0,
118.1, 111.7, 111.4, 107.9; HRMS (ESI-TOF) m/z [M + H]+ calcd for
C21H15N2 295.1235, found 295.1220.
2-(4-Nitrophenyl)-3-phenyl-1H-indole (8g). Orange solid (60.2
1
mg, 38%): H NMR (400 MHz, CDCl3) δ 8.38 (s, 1H), 8.12 (d, J =
8.8 Hz, 2H), 7.63 (d, J = 8.0 Hz, 1H), 7.52 (d, J = 8.9 Hz, 2H), 7.46−
7.33 (m, 6H), 7.29 (t, J = 7.4 Hz, 1H), 7.16 (t, J = 7.5 Hz, 1H); 13C
NMR (100 MHz, CDCl3) δ 146.5, 139.1, 136.5, 134.1, 131.2, 130.1,
128.9, 128.7, 128.2, 127.1, 124.0, 124.0, 121.0, 120.2, 118.2, 111.2;
HRMS (ESI-TOF) m/z [M + H]+ calcd for C20H15N2O2 315.1134,
found 315.1131.
4-(2-Phenyl-1H-indol-3-yl)phenol (9b).33 White solid (43.0 mg,
30%): 1H NMR (400 MHz, DMSO-d6) δ 11.42 (s, 1H), 9.40 (s, 1H),
7.52−7.11 (m, 10H), 7.02 (t, J = 7.9 Hz, 1H), 6.82 (d, J = 8.6 Hz,
2H); 13C NMR (100 MHz, DMSO-d6) δ 155.7, 135.9, 133.2, 132.6,
130.7, 128.3, 128.3, 127.8, 127.1, 125.5, 121.7, 119.3, 118.6, 115.5,
113.4, 111.3; HRMS (ESI-TOF) m/z [M + H]+ calcd for C20H16NO
286.1232, found 286.1224.
3-(4-Nitrophenyl)-2-phenyl-1H-indole (9g).39 Orange solid (23.0
mg, 15%): 1H NMR (400 MHz, DMSO-d6) δ 11.87 (s, 1H), 8.22 (d, J
= 8.0 Hz, 2H), 7.66−7.35 (m, 9H), 7.22 (t, J = 7.6 Hz, 1H), 7.12 (t, J
= 7.5 Hz, 1H); 13C NMR (100 MHz, DMSO-d6) δ 144.9, 142.9, 136.2,
131.7, 130.1, 128.7, 128.6, 128.2, 126.9, 123.8, 122.4, 120.4, 118.2,
111.8, 111.0; HRMS (ESI-TOF) m/z [M + H]+ calcd for C20H15N2O2
315.1134, found 315.1135.
N-(4-(3-Phenyl-1H-indol-2-yl)phenyl)acetamide (8c). Pale yellow
1
solid (65.0 mg, 40%): H NMR (400 MHz, DMSO-d6) δ 11.47 (s,
1H), 10.01 (s, 1H), 7.56 (d, J = 8.6 Hz, 2H), 7.50−7.32 (m, 8H), 7.28
(t, J = 8.7 Hz, 1H), 7.14 (t, J = 8.1 Hz, 1H), 7.03 (t, J = 8.0 Hz, 1H),
2.05 (s, 3H); 13C NMR (100 MHz, DMSO-d6) δ 168.3, 138.6, 135.9,
135.3, 134.0, 129.6, 128.5, 128.5, 127.9, 127.0, 125.9, 121.7, 119.6,
118.8, 118.3, 112.6, 111.3, 23.9; HRMS (ESI-TOF) m/z [M + H]+
calcd for C22H19N2O 327.1497, found 327.1492.
X-ray Diffraction. X-ray diffraction data were measured on a
diffractometer with graphite-monochromated MoKα radiation (λ =
0.71073 Å) at 298(2) K. The structures were solved by direct methods
with SIR9740 and refined with full-matrix least-squares calculations on
F2 using SHELXL-97.41 Crystallographic data have been deposited at
the Cambridge Crystallographic Data Centre under the reference nos.
CCDC962465-962466. Copies of the data can be obtained, free of
charge, on application to the Director, CCDC, 12 Union Road,
Computational Details. All geometrical structures of reaction
were optimized by employing the hybrid density functional B3LYP
method. For the basis set, the LANDL2DZ effective core potential
(ECP)42−44 and LANL2DZspdf+ECP45 basis sets were used for
palladium and iodine atoms, respectively. The remaining atoms were
treated with the 6-31G(d,p) basis set. All minimum and transition state
structures were confirmed by the frequency calculation in which all
minimum structures had no imaginary frequency and each transition
state structure had only one imaginary frequency. To investigate the
effect of DMF solvent on the energetic profile, all geometrical
structures were reoptimized at the same level within the bulk solvent
treating by the polarizable continuum model (PCM).46 The free
energies at 353.15 K and 1 atm of the gas-phase and PCM models
N-(4-(2-Phenyl-1H-indol-3-yl)phenyl)acetamide (9c). Pale yellow
1
solid (70.4 mg, 43%): H NMR (400 MHz, DMSO-d6) δ 11.50 (s,
1H), 9.97 (s, 1H), 7.61 (d, J = 8.5 Hz, 2H), 7.50−7.24 (m, 9H), 7.15
(t, J = 8.0 Hz, 1H), 7.04 (t, J = 7.9 Hz, 1H), 2.07 (s, 3H); 13C NMR
(100 MHz, DMSO-d6) δ 168.2, 137.4, 136.0, 133.7, 132.5, 129.89,
129.79, 128.4, 128.03, 127.97, 127.3, 121.9, 119.5, 119.2, 118.6, 113.0,
111.4, 23.9; HRMS (ESI-TOF) m/z [M + H]+ calcd for C22H19N2O
327.1497, found 327.1493.
2-(4-Bromophenyl)-3-phenyl-1H-indole (8d).34 Yellow solid (31.8
1
mg, 18%): H NMR (400 MHz, CDCl3) δ 8.19 (s, 1H), 7.66 (d, J =
7.98 Hz, 1H), 7.47−7.22 (m, 11H), 7.15 (t, J = 7.5 Hz, 1H); 13C NMR
(100 MHz, CDCl3) δ 135.9, 134.6, 132.7, 131.8, 131.6, 130.0, 129.5,
128.7, 128.6, 126.4, 123.0, 121.7, 120.6, 119.7, 115.6, 110.9; HRMS
(ESI-TOF) m/z [M + H]+ calcd for C20H15NBr 348.0388, found
348.0380.
3-(4-Bromophenyl)-2-phenyl-1H-indole (9d).35 Yellow solid (23.9
1
mg, 14%): H NMR (400 MHz, CDCl3) δ 8.26 (s, 1H), 7.63 (d, J =
8.0 Hz, 1H), 7.48 (d, J = 8.4 Hz, 2H), 7.45−7.22 (m, 9H), 7.16 (t, J =
7.9 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 135.8, 134.3, 134.0,
12708
dx.doi.org/10.1021/jo402304s | J. Org. Chem. 2013, 78, 12703−12709